Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURE study of early adalimumab use in Crohn's disease
2013-003199-11Phase 4Completed
- Sponsor
- GETAID
- Start
- Jul 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of adalimumab in Crohn's disease, sponsored by GETAID. Primary endpoint: Sustained deep remission rate after adalimumab discontinuation. Started Jul 2015; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2013-003199-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003199-11.